Cigna Group — Director's Dealing 2024

Aug 21, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cigna Group (CI)
CIK: 0001739940
Period of Report: 2024-08-19

Reporting Person: DeLaney William J III (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-08-19	Common Stock, $.01 Par Value	M	2691.0000	$175.0938	Acquired	20230.0000	Direct
2024-08-19	Common Stock, $.01 Par Value	S	2691.0000	$342.6800	Disposed	17539.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-08-19	Employee Stock Option (Right to Buy)	$175.0938	M	2691.0000	Disposed	2025-05-06	Common Stock, $.01 Par Value (2691.0000)	Direct

Footnotes

F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2024.

F2: These stock options were granted on May 6, 2015 and were fully vested at the closing of the acquisition of Express Scripts Holding Company on December 20, 2018.